266 related articles for article (PubMed ID: 24600452)
1. The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation.
Roberts V; Stagg J; Dwyer KM
Front Immunol; 2014; 5():64. PubMed ID: 24600452
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signaling in liver disease.
Vaughn BP; Robson SC; Longhi MS
Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
[TBL] [Abstract][Full Text] [Related]
3. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases.
Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM
Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916
[TBL] [Abstract][Full Text] [Related]
4. Immune cell expression patterns of CD39/CD73 ectonucleotidases in rodent models of cardiac arrest and resuscitation.
Aoki T; Wong V; Yin T; Nakamura E; Endo Y; Hayashida K; Robson SC; Nandurkar H; Diamond B; Kim SJ; Murao A; Wang P; Becker LB; Shinozaki K
Front Immunol; 2024; 15():1362858. PubMed ID: 38545102
[TBL] [Abstract][Full Text] [Related]
5. Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation.
Chernogorova P; Zeiser R
J Biomed Biotechnol; 2012; 2012():208204. PubMed ID: 23125523
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
7. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
8. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
9. CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Kishore BK; Robson SC; Dwyer KM
Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180
[TBL] [Abstract][Full Text] [Related]
10. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
11. Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A
Kelestemur T; Németh ZH; Pacher P; Beesley J; Robson SC; Eltzschig HK; Haskó G
Respir Res; 2023 Jul; 24(1):186. PubMed ID: 37438813
[TBL] [Abstract][Full Text] [Related]
12. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.
Crikis S; Lu B; Murray-Segal LM; Selan C; Robson SC; D'Apice AJ; Nandurkar HH; Cowan PJ; Dwyer KM
Am J Transplant; 2010 Dec; 10(12):2586-95. PubMed ID: 20840479
[TBL] [Abstract][Full Text] [Related]
13. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
[TBL] [Abstract][Full Text] [Related]
14. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
15. Generation and Function of Non-cell-bound CD73 in Inflammation.
Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
Front Immunol; 2019; 10():1729. PubMed ID: 31404305
[TBL] [Abstract][Full Text] [Related]
16. The impact of purinergic signaling on renal ischemia-reperfusion injury.
Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
[TBL] [Abstract][Full Text] [Related]
17. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC
Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736
[TBL] [Abstract][Full Text] [Related]
18. Ectonucleotidases in Intestinal and Hepatic Inflammation.
Vuerich M; Robson SC; Longhi MS
Front Immunol; 2019; 10():507. PubMed ID: 30941139
[TBL] [Abstract][Full Text] [Related]
19. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
20. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
